The interleukin-10 gene promoter polymorphism (-1082) does not correlate with clinical outcome in diffuse large B-cell lymphoma

Blood ◽  
2005 ◽  
Vol 105 (12) ◽  
pp. 4894-4895 ◽  
Author(s):  
Mattias Berglund ◽  
Ulf Thunberg ◽  
Göran Roos ◽  
Richard Rosenquist ◽  
Gunilla Enblad
Keyword(s):  
Clinical Outcome ◽  
B Cell ◽  
Cell Lymphoma ◽  
Gene Promoter ◽  
B Cell Lymphoma ◽  
Interleukin 10 ◽  
Promoter Polymorphism ◽  
Large B Cell Lymphoma ◽  
Large B Cell ◽  
Gene Promoter Polymorphism

scholarly journals Concomitant statin use does not impair the clinical outcome of patients with diffuse large B cell lymphoma treated with rituximab-CHOP

2010 ◽  
Vol 89 (8) ◽  
pp. 783-787 ◽  
Author(s):  
Panagiotis Samaras ◽  
Helen Heider ◽  
Sarah R. Haile ◽  
Ulf Petrausch ◽  
Niklaus G. Schaefer ◽  
...  
Keyword(s):  
Clinical Outcome ◽  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Large B Cell Lymphoma ◽  
Large B Cell ◽  
Statin Use

Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP

2009 ◽  
Vol 135 (10) ◽  
pp. 1421-1428 ◽  
Author(s):  
Takeshi Hara ◽  
Hisashi Tsurumi ◽  
Naoe Goto ◽  
Nobuhiro Kanemura ◽  
Takeshi Yoshikawa ◽  
...  
Keyword(s):  
Clinical Outcome ◽  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Soluble Fas ◽  
Large B Cell Lymphoma ◽  
Large B Cell

scholarly journals Interaction between BCL2 and Interleukin-10 Gene Polymorphisms Alter Outcomes of Diffuse Large B-Cell Lymphoma following Rituximab Plus CHOP Chemotherapy

2009 ◽  
Vol 15 (6) ◽  
pp. 2107-2115 ◽  
Author(s):  
Yeon Hee Park ◽  
Sang Kyun Sohn ◽  
Jong Gwang Kim ◽  
Myung-Hoon Lee ◽  
Hong Suk Song ◽  
...  
Keyword(s):  
B Cell ◽  
Gene Polymorphisms ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Interleukin 10 ◽  
Chop Chemotherapy ◽  
Large B Cell Lymphoma ◽  
Large B Cell
Sign in / Sign up

Export Citation Format

Share Document